Zymeworks Inc. ZYME 深 沪
等待开盘 05-11 09:30:00 美东时间
23.93
-2.670
-10.04%
华盛通- 最 高27.96
- 今 开26.21
- 成交量 117.31万股
- 最 低 23.39
- 昨 收 26.60
- 总市值 138.25万
- 52周最高 29.75
- 市盈率 静 --
- 换手率 2030.52%
- 52周最低 11.02
- 委 比 41.11%
- 总股本 5.78万
- 历史最高 59.03
- 量 比 3.35
- 振 幅 17.18%
- 历史最低 1.10
- 每 手 1
- 风险率 5.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For March 2, 2026
Companies Reporting Before The Bell • Zymeworks (NASDAQ:ZYME) is expected to re...
03-02 19:11
Earnings Breakdown: Zymeworks Q4
The Q4 earnings report for Zymeworks (NASDAQ:ZYME) was released on Monday, Marc...
03-02 19:06
Market-Moving News for November 17th
GOOG: 5% | Alphabet Inc shares are trading higher after Berkshire Hathaway disclosed a new stake in the company. ZYME: 61% | Zymeworks shares are trading higher after the company and its partners reported
2025-11-17 20:23
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
首款胃癌“国货之光”！石药/康宁杰瑞HER2双抗撬动百亿市场
（来源：求实药社） 2025年9月11日，石药集团与康宁杰瑞共同宣布，其合作开发的HER2双特异性抗体KN026（安尼妥单抗注射液）新药上市申请（NDA）已获中...
2025-09-16 12:05
【天风医药杨松团队|公司点评】百济神州：2025 Q2 利润端大幅超预期，连续两季度 GAAP 利润为正
（来源：一棵大松树） 公司发布2025年半年度主要财务数据，2025H1总收入24.33亿美元，同比增长45%；GAAP净利润和经调整后净利润分...
2025-08-27 12:59
从烧钱到赚钱！“创新药一哥”首次盈利
2025年8月6日，百济神州发布2025年半年度主要财务数据公告：营业总收入175.18亿元人民币，同比增长46.0%；产品收入173.60亿元，同比增长45...
2025-08-13 07:34
百济神州首次实现半年度盈利！泽布替尼销售额破百亿元，后续管线面临激烈竞争
百济神州（688235.SH、06160.HK）终于迎来半年度盈利。8月6日，百济神州公布2025年半年度主要财务数据，公告显示，2025年上半年，百济神州实现...
2025-08-07 20:48
Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer
Zymeworks' zanidatamab receives conditional approval in China for HER2+ biliary tract cancer, becoming the first and only dual HER2-targeted bispecific antibody approved for this indication. The company is eligible for a $20 million milestone payment and up to $144 million in additional payments, reflecting its global progress in addressing high unmet need in this disease area.
2025-05-30 10:00
